Pituitary Apoplexy Induced by Anticoagulant Therapy in Patient with Acute Coronary Syndrome

Case Report


  • Michael Johan General Practitioner, Mitra Keluarga Kemayoran Hospital
  • Handry Pangestu Internal Medicine Department, Mitra Keluarga Kemayoran Hospital




Anticoagulant, apoplexy, pituitary tumour


Pituitary apoplexy defined as bleeding or infarct on pituitary gland often occurs in undiagnosed pituitary tumour. Mechanisms thought to trigger pituitary apoplexy are fluctuations in blood pressure, hormonal stimulation of the pituitary gland, coagulation disorders, or vascular disorders. The case is a male, aged 73 years, from India, with complaints of chest pain in the last four hours. Electrocardiography (ECG) and laboratory examination results lead to an acute coronary syndrome (ACS) event. Patients are given fondaparinux, aspirin, and clopidogrel. On the 4th day of hospitalization, the patient experienced a severe headache, projectile vomiting, and double vision. Radiological examination reveals a pituitary tumour with signs of diffuse haemorrhage compressing the optic chiasma, suggesting a pituitary tumour apoplexy. Hormone function tests show a non-functioning pituitary tumour. The blood thinners were discontinued, vitamin K and dexamethasone were given to reduce the patient symptoms. After a few days, the headaches and double vision began to improve. Head MRI showed stable mass of bleeding. Pituitary tumour may be a relative contraindication to dual antiplatelets and anticoagulants in acute coronary syndromes especially in group with renal or liver comorbidities.


Download data is not yet available.

Author Biography

Handry Pangestu, Internal Medicine Department, Mitra Keluarga Kemayoran Hospital

Internal Medicine Department


Capatina C, Inder W, Karavitaki N, Wass JAH. Management of endocrine disease: Pituitary tumour apoplexy. Eur J Endocrinol. 2015;172(5):R179-90.

Ranabir S, Baruah MP. Pituitary apoplexy. Indian J Endocrinol Metab. 2011;15:S188-96.

Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol. 2010;72(3):377–82.

Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev. 2015;36(6):622–45.

Tansel T, Ugurlucan M, Onursal E. Pituitary apoplexy following coronary artery bypass grafting report of a case. Acta Chir Belg. 2010;110(4):484–6.

Kılıclı F, Dokmetas H, Gurelik M. Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma. Singapore Med J. 2010;51:e179-81.

Uemura M, Miyashita F, Shimomura R, Fujinami J, Toyoda K. Pituitary apoplexy during treatment with dabigatran. Neurol Clin Neurosci. 2013;1(2):82–3.

Kumar V, Kataria R, Mehta V. Dengue hemorrhagic fever: A rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian Journal of Ophtalmology. 2011;59:311–2.

Di Ieva A, Weckman A, Di Michele J, Rotondo F, Grizzi F, Kovacs K, et al. Microvascular morphometrics of the hypophysis and pituitary tumors: From bench to operating theatre. Microvasc Res. 2013;89:7–14.

Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New England Journal of Medicine 1983;309(7):396–403.

Singh D, Gupta K, Vacek JL. Anticoagulation and antiplatelet therapy in acute coronary syndromes. Cleve Clin J Med. 2014;81(2):103–14.

Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. Circulation 2014;130(25):e344–426.

Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;354(14):1464–76.

Tersalvi G, Biasco L, Cioffi GM, Pedrazzini G. Acute coronary syndrome, antiplatelet therapy, and bleeding: A clinical perspective. J Clin Med. 2020;9(7):2064-83.

Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, et al. The pharmacokinetics of fondaparinux sodium in healthy volunteers. Clin Pharmacokinet. 2002;41(2):1–9.

Vicente A, Lecumberri B, Galvez MA. Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy. Endocrinol Nutr. 2013;60(10):582.e1-582.e12.

Santos AR, Bello CT, Sousa A, Duarte JS, Campos L. Pituitary apoplexy following systemic anticoagulation. Vol. 6, European journal of case reports in internal medicine. Italy; 2019. p. 1254.

Mudalagiri M, Ayyar V, Bantwal G, George B, Appaiah S. The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience. Indian J of Endocrinol and Metab. 2022;26:S37.

Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf ). 2011;74(1):9–20.

Fan Y, Bao X, Wang R. Conservative treatment cures an elderly pituitary apoplexy patient with oculomotor paralysis and optic nerve compression: A case report and systematic review of the literature. Clin Interv Aging 2018;13:1981–5.




How to Cite

Johan, M., & Pangestu, H. (2024). Pituitary Apoplexy Induced by Anticoagulant Therapy in Patient with Acute Coronary Syndrome: Case Report. Cermin Dunia Kedokteran, 51(7), 396–399. https://doi.org/10.55175/cdk.v51i7.1023